| Cat. # | Size | Qty. | Price |
|---|---|---|---|
| 54513T | 1 Kit (8 x 20 microliters) |
|
| Product Includes | Quantity | Applications | Reactivity | MW(kDa) | Isotype |
|---|---|---|---|---|---|
| PRMT1 (E5A8F) Rabbit mAb 79780 | 20 µl |
|
H M R Mk | 41 | Rabbit IgG |
| PRMT2 (E5R1P) Rabbit mAb 67007 | 20 µl |
|
H Mk | 52 | Rabbit IgG |
| PRMT3 (E9R7B) Rabbit mAb 72593 | 20 µl |
|
H | 70 | Rabbit IgG |
| PRMT4/CARM1 (C31G9) Rabbit mAb 3379 | 20 µl |
|
H M R Mk | 63 | Rabbit IgG |
| PRMT5 (D5P2T) Rabbit mAb 79998 | 20 µl |
|
H M R Mk | 73 | Rabbit IgG |
| PRMT6 (D5A2N) Rabbit mAb 14641 | 20 µl |
|
H M R | 42 | Rabbit IgG |
| PRMT7 (D1K6R) Rabbit mAb 14762 | 20 µl |
|
H M Mk | 78 | Rabbit IgG |
| PRMT8 (E2R7O) Rabbit mAb 83283 | 20 µl |
|
M | 45 | Rabbit IgG |
| Anti-rabbit IgG, HRP-linked Antibody 7074 | 100 µl |
|
Rab | Goat |
Product Information
Monoclonal antibodies are produced by immunizing animals with synthetic peptides corresponding to residues surrounding Leu337 of human PRMT1 protein, Gly14 of human PRMT2 protein, Gly44 of human PRMT3 protein, Ala62 of human PRMT6 protein, Val233 of human PRMT7 protein, Gly323 of human PRMT8 protein, and corresponding to the amino
terminus of human PRMT4/CARM1 protein. Monoclonal antibody is produced by immunizing animals with recombinant human PRMT5 protein.
Arginine methylation is a prevalent PTM found on both nuclear and cytoplasmic proteins. Arginine methylated proteins are involved in many different cellular processes, including transcriptional regulation, signal transduction, RNA metabolism, and DNA damage repair (1-3). Arginine methylation is carried out by the arginine N-methyltransferase (PRMT) family of enzymes that catalyze the transfer of a methyl group from S-adenosylmethionine (AdoMet) to a guanidine nitrogen of arginine (4). There are three different types of arginine methylation: asymmetric dimethylarginine (aDMA, omega-NG,NG-dimethylarginine), where two methyl groups are placed on one of the terminal nitrogen atoms of the guanidine group of arginine; symmetric dimethylarginine (sDMA, omega-NG,NG-dimethylarginine), where one methyl group is placed on each of the two terminal guanidine nitrogens of arginine; and monomethylarginine (MMA, omega-NG-methylarginine), where a single methyl group is placed on one of the terminal nitrogen atoms of arginine. Each of these modifications has potentially different functional consequences. Though all PRMT proteins catalyze the formation of MMA, Type I PRMTs (PRMT1, 3, 4, 6, and 8) add an additional methyl group to produce aDMA, while Type II PRMTs (PRMT5 and 7) produce sDMA. Methylated arginine residues often reside in glycine-arginine rich (GAR) protein domains, such as RGG, RG, and RXR repeats (5). However, PRMT4/CARM1 and PRMT5 methylate arginine residues within proline-glycine-methionine rich (PGM) motifs (6).
Explore pathways related to this product.
STRING - Known and Predicted Protein-Protein Interactions.
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.
PhosphoSitePlus®